| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.069 | 0.2 |